Stockreport

Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia [Yahoo! Finance]

BIO-PATH HOLDINGS INC  (BPTH) 
Last bio-path holdings inc earnings: 11/14 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: biopathholdings.com
PDF Bio-Path Holdings, Inc. Wed, February 12, 2025 at 10:01 PM GMT+1 5 min read In This Article BPTH Bio-Path Holdings, Inc. Study Progresses to Fourth Higher 9 [Read more]